Compounds > 3,4-dihydroxyphenylacetic acid
Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Acute Liver Injury, Drug-Induced

3,4-dihydroxyphenylacetic acid has been researched along with Acute Liver Injury, Drug-Induced in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xue, H1
Xie, W1
Jiang, Z1
Wang, M1
Wang, J1
Zhao, H1
Zhang, X1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Acute Liver Injury, Drug-Induced

ArticleYear
3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen (APAP)-induced liver injury through activation of Nrf-2.
    Xenobiotica; the fate of foreign compounds in biological systems, 2016, Volume: 46, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Mice

2016